Howland Capital Management LLC Astrazeneca PLC Transaction History

Howland Capital Management LLC

$2.05 Billion
Q1 2024

A detailed history of Howland Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Howland Capital Management LLC holds 11,274 shares of AZN stock, worth $887,376. This represents 0.04% of its overall portfolio holdings.

Number of Shares

11,274

Previous 11,308 0.3%

Holding current value

$887,376

Previous $761,000 0.26%

% of portfolio

0.04%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$61.03 - $69.57 $2,075 - $2,365	-34 Reduced 0.3%	11,274 $763,000
Q4 2023 Jan 23, 2024	SELL	$61.89 - $69.28 $30,945 - $34,640	-500 Reduced 4.23%	11,308 $761,000
Q2 2023 Jul 28, 2023	SELL	$69.91 - $75.81 $133,598 - $144,872	-1,911 Reduced 13.93%	11,808 $845,000
Q1 2023 May 05, 2023	SELL	$63.15 - $71.6 $53,488 - $60,645	-847 Reduced 5.81%	13,719 $952,000
Q3 2022 Oct 17, 2022	SELL	$53.02 - $135.75 $1,431 - $3,665	-27 Reduced 0.19%	14,566 $799,000

Q2 2022 Jul 22, 2022	SELL	$59.26 - $71.14 $59,260 - $71,140	-1,000 Reduced 6.41%	14,593 $964,000
Q1 2022 Apr 27, 2022	SELL	$55.72 - $67.12 $26,912 - $32,418	-483 Reduced 3.0%	15,593 $1.03 Million
Q4 2021 Jan 26, 2022	BUY	$54.02 - $63.83 $5,834 - $6,893	108 Added 0.68%	16,076 $936,000
Q3 2021 Oct 25, 2021	SELL	$55.56 - $60.79 $52,948 - $57,932	-953 Reduced 5.63%	15,968 $959,000
Q4 2020 Jan 26, 2021	SELL	$48.52 - $58.02 $44,201 - $52,856	-911 Reduced 5.11%	16,921 $846,000
Q3 2020 Oct 26, 2020	SELL	$53.07 - $61.1 $1,220 - $1,405	-23 Reduced 0.13%	17,832 $977,000
Q2 2020 Jul 15, 2020	SELL	$43.1 - $55.31 $50,771 - $65,155	-1,178 Reduced 6.19%	17,855 $944,000
Q1 2020 Apr 13, 2020	SELL	$37.79 - $51.33 $23,996 - $32,594	-635 Reduced 3.23%	19,033 $850,000
Q4 2019 Jan 23, 2020	SELL	$42.46 - $50.46 $67,511 - $80,231	-1,590 Reduced 7.48%	19,668 $981,000
Q3 2019 Oct 22, 2019	BUY	$40.12 - $45.47 $69,126 - $78,344	1,723 Added 8.82%	21,258 $947,000
Q4 2018 Jan 23, 2019	SELL	$36.86 - $41.49 $147,440 - $165,960	-4,000 Reduced 17.0%	19,535 $742,000
Q3 2018 Oct 25, 2018	BUY	$34.76 - $39.72 $122,876 - $140,410	3,535 Added 17.68%	23,535 $931,000
Q2 2018 Jul 23, 2018	SELL	$34.55 - $37.05 $69,100 - $74,100	-2,000 Reduced 9.09%	20,000 $702,000
Q3 2017 Oct 30, 2017	BUY	$28.96 - $34.0 $637,120 - $748,000	22,000	22,000 $745,000

Others Institutions Holding AZN

# of Institutions

1,269

Shares Held

483M

Call Options Held

5.99M

Put Options Held

5.22M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $244B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howland Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Howland Capital Management LLC with notifications on news.

Account

Howland Capital Management LLC Astrazeneca PLC Transaction History